Search Results - "Recker F"

Teledidactic Versus Hands-on Teaching of Abdominal, Thoracic, and Thyroid Ultrasound—The TELUS II Study.

Authors: Höhne, E. Recker, F. Brossart, P. et al.

Source: JGIM: Journal of General Internal Medicine. Aug2024, Vol. 39 Issue 10, p1803-1810. 8p.

Impact of COVID-19 on gynaecological patient care: results of patient's survey with 327 patients.

Authors: Recker, F. Dohmen, S. Egger, E. K. et al.

Source: Archives of Gynecology & Obstetrics. Feb2022, Vol. 305 Issue 2, p389-395. 7p.

Vertiefte Analyse zweier Studien zum Prostatakarzinom-Screening -- Was macht Sinn?

Authors: Recker, F.¹ franz.recker@ksa.ch

Source: Praxis (1661-8157). 2/3/2010, Vol. 99 Issue 3, p183-185. 3p.

Breast assessment using next generation handheld ultrasound device based on silicon chips: a pilot study in senology.

Authors: Plöger, R. Ludwig, C. Nowozin, G. et al.

Source: Archives of Gynecology & Obstetrics. 1/24/2026, Vol. 313 Issue 1, p1-11. 11p.

Design and implementation of a microlearning-based OSCE preparatory curriculum in obstetrics: a pilot study.

Authors: Michlmayr, N. Mitofsky, J. Haverkamp, N. et al.

Source: Archives of Gynecology & Obstetrics. Nov2025, Vol. 312 Issue 5, p1599-1604. 6p.

Prevalence of joint, entheseal, tendon, and bursal findings in young, healthy individuals by musculoskeletal ultrasound.

Authors: Schreiner, JK Scheicht, D Karakostas, P et al.

Source: Scandinavian Journal of Rheumatology. Jan2023, Vol. 52 Issue 1, p51-59. 9p.

Vesicoamniotic shunting for fetal megacystis in the first trimester with a Somatex^® intrauterine shunt.

Authors: Strizek, B. Gottschalk, I. Recker, F. et al.

Source: Archives of Gynecology & Obstetrics. Jul2020, Vol. 302 Issue 1, p133-140. 8p. 4 Diagrams, 1 Chart.

V44 THE ANTEGRADE INTER/INTRA/EXTRAFASCIAL DA VINCI PROSTATECTOMY AFTER TRANSRECTAL INJECTION

Authors: Recker, F. Seiler, D. Werthemann, P.

Source: European Urology Supplements. Mar2008, Vol. 7 Issue 3, p340-340. 1p.

Shaping the future of obstetric/gynecological ultrasound training.

Authors: Matschl, J. Gembruch, U. Strizek, B. et al.

Source: Ultrasound in Obstetrics & Gynecology. Jun2024, Vol. 63 Issue 6, p717-722. 6p.

Features and preliminary results of prostate cancer screening in Canton Aargau, Switzerland.

Authors: Kwiatkowski, M. Huber, A. Stamm, B. et al.

Source: BJU International. Dec2003 Supplement 2, Vol. 92, p44-47. 4p.

1129 - The relation between baseline PSA, cancer detection and PC death, long-term data from ERSPC.

Authors: Roobol, M. Remmers, S. Hugosson, J. et al.

Source: European Urology Supplements. Mar2019, Vol. 18 Issue 1, pe1528-e1529. 2p.

1131 - Influence of regular aspirin intake on PSA values, prostate cancer incidence and overall survival in a prospective screening trial (ERSPC Aarau).

Authors: Gstrein, L. Mortezavi, A. Millan, C. et al.

Source: European Urology Supplements. Mar2019, Vol. 18 Issue 1, pe1531-e1531. 1p.

1097 Oncologic outcome after active treatment in men initially on active surveillance: Impact of population-based screening on prostate cancer progression. The experience of the Swiss arm of the ERSPC

Authors: Seiler, D. Randazzo, M. Chun, F. et al.

Source: European Urology Supplements. Feb2012, Vol. 11 Issue 1, pe1097-e1097a. 2p.

785 Outcomes after various primary treatment for non-metastasised prostate cancer. A report from the European randomized screening trial for prostate cancer (ERSPC)

Authors: Carlsson, S. Moss, S. Auvinen, A. et al.

Source: European Urology Supplements. Feb2012, Vol. 11 Issue 1, pe785-e785a. 2p.

92 Swiss prostate-check: A population based risk-calculator for next generation prostate cancer screening.

Authors: Kwiatkowski, M. Wyler, S.F. Prause, L. et al.

Source: European Urology Supplements. Mar2016, Vol. 15 Issue 3, pe92-e92. 1p.

Cost-effectiveness of prostate cancer screening: a simulation study based on ERSPC data.

Authors: Heijnsdijk, E A M de Carvalho, T M Auvinen, A et al.

Source: JNCI: Journal of the National Cancer Institute. 2015 Jan, Vol. 107 Issue 1, p366-366. 1p.

855 Future risk for intermediate and high risk prostate cancer in men with baseline PSA of 1-2.99ng/ml and low free-to-total PSA-ratio in a prospective population-based screening trial.

Authors: Randazzo, M. Beatrice, J. Huber, A. et al.

Source: European Urology Supplements. Apr2014, Vol. 13 Issue 1, pe855-e855. 1p.

206 Fine-mapping of the Kallikrein region and its role in prostate cancer aggressiveness: Results from a Canadian cohort and the European Randomized Study for Prostate Cancer Screening.

Authors: Briollais, L. Xu, J. Kwiatkowski, M. et al.

Source: European Urology Supplements. Apr2014, Vol. 13 Issue 1, pe206-e206. 1p.

272 The HAROW study – an observational health service study, capturing current low-risk-prostate cancer treatment practice patterns in Germany.

Authors: Becker, A. Kluth, L.A. Beermann, S. et al.

Source: European Urology Supplements. Mar2013, Vol. 12 Issue 1, pe272-e272. 1p.

133 PSA-pyramid in men with low range PSA: PCa incidence and mortality – a plea for risk-based prostate cancer screening strategy in the European Randomized study of Screening for Prostate Cancer (ERSPC), Aarau.

Authors: Randazzo, M. Seiler, D. Beatrice, J. et al.

Source: European Urology Supplements. Mar2013, Vol. 12 Issue 1, pe133-e134. 0p.